Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives

다국어 초록 (Multilingual Abstract)

Objectives: Malaria has been a major global health problem in recent times with increasing mortality. Current treatment methods include parasiticidal drugs and vaccinations. However, resistance among malarial parasites to the existing drugs has emerged as a significant area of concern in anti-malarial drug design. Researchers are now desperately looking for new targets to develop anti-malarials drug which is more target specific. Malarial parasites harbor a plastid-like organelle known as the ‘apicoplast’, which is thought to provide an exciting new outlook for the development of drugs to be used against the parasite. This review elaborates on the current state of development of novel compounds targeted againstemerging malaria parasites.
Methods: The apicoplast, originates by an endosymbiotic process, contains a range of metabolic pathways and housekeeping processes that differ from the host body and thereby presents ideal strategies for anti-malarial drug therapy. Drugs are designed by targeting the unique mechanism of the apicoplasts genetic machinery. Several anabolic and catabolic processes, like fatty acid, isopenetyl diphosphate and heme synthess in this organelle, have also been targeted by drugs.
Results: Apicoplasts offer exciting opportunities for the development of malarial treatment specific drugs have been found to act by disrupting this organelle’s function, which wouldimpede the survival of the parasite.
Conclusion: Recent advanced drugs, their modes of action, and their advantages in the treatment of malaria by using apicoplasts as a target are discussed in this review which thought to be very useful in desigining anti-malarial drugs. Targetting the genetic machinery of apicoplast shows a great advantange regarding anti- malarial drug design. Critical knowledge of these new drugs would give a healthier understanding for deciphering the mechanism of action of anti-malarial drugs when targeting apicoplasts to overcome drug resistance.

참고문헌 (Reference)

1 Surolia N, "de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite" 187 (187): 744-750, 1992

2 Goodman CD, "Ycf93 (Orf105), a small apicoplast-encoded membrane protein in the relict plastid of the malaria parasite Plasmodium falciparum that is conserved in Apicomplexa" 9 (9): e91178-, 2014

3 World Health Organization, "World Malaria Report 2015" World Health Organization

4 Bouchut A, "Vesicles bearing Toxoplasma apicoplast membrane proteins persist following loss of the relict plastid or Golgibody disruption" 9 (9): e112096-, 2014

5 Ralph SA, "Tropical infectious diseases : metabolic maps and functions of the Plasmodium falciparum apicoplast" 2 (2): 203-216, 2004

6 McLeod R, "Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I" 31 (31): 109-113, 2001

7 Gray MW, "Transcription in chloroplasts and mitochondria : a tale of two polymerases" 6 (6): 1-3, 1998

8 Lindner J, "Trafficked proteins-druggable in Plasmodium falciparum" 2013 : e435981-, 2013

9 Gisselberg JE, "The suf iron-sulfur cluster synthesis pathway is required for apicoplast maintenance in malaria parasites" 9 (9): e1003655-, 2013

10 Budimulja AS, "The sensitivity of Plasmodium protein synthesis to prokaryotic ribosomal inhibitors" 84 (84): 137-141, 1997

11 Gleeson MT, "The plastid in Apicomplexa : what use is it?" 30 (30): 1053-1070, 2000

12 Ke H, "The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages" 289 (289): 34827-34837, 2014

13 Liting L, "The evolution, metabolism and functions of the apicoplast" 365 (365): 749-763, 2010

14 Goodman CD, "The effects of anti-bacterials on the malaria parasite Plasmodium falciparum" 152 (152): 181-191, 2007

15 Chaubey S, "The apicoplast of Plasmodium falciparum is translationally active" 56 (56): 81-89, 2005

16 Stuart A. Ralph, "The apicoplast as an antimalarial drug target" 4 (4): 145-151, 2001

17 Macrae JI, "The apicoplast : a key target to cure malaria" 18 (18): 3490-3504, 2012

18 Lalève A, "The antimalarial drug primaquine targets Fe-S cluster proteins and yeast respiratory growth" 7 : 21-29, 2016

19 Dahl EL, "Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum" 50 (50): 3124-3131, 2006

20 Haider A, "Targeting and function of proteins mediating translation initiation in organelles of Plasmodium falciparum" 96 (96): 796-814, 2015

21 Barnes KI, "Sulfadoxine-pyrimethamine pharmacokinetics in malaria : pediatric dosing implications" 80 (80): 582-596, 2006

22 Cowman AF, "Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine" 91 (91): 1143-1147, 2004

23 Gupta A, "Reduced ribosomes of the apicoplast and mitochondrion of Plasmodium spp. and predicted interactions with antibiotics" 4 (4): e140045-, 2014

24 Gupta A, "Recycling factors for ribosome disassembly in the apicoplast and mitochondrion of Plasmodium falciparum" 88 (88): 891-905, 2013

25 Chandey M, "Quinine-resistant severe falciparum malaria in north India : documentation" 4 (4): 99-102, 2013

26 Botté CY, "Plasmodium falciparum apicoplast drugs: targets or off-targets" 112 (112): 1269-1283, 2012

27 Eastman RT, "Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites" 55 (55): 3908-3916, 2011

28 Arisue N, "Phylogeny and evolution of apicoplasts and apicomplexan parasites" 64 (64): 254-259, 2015

29 Dellibovi-Ragheb TA, "Parasites FeS up: iron-sulfur cluster biogenesis in eukaryotic pathogens" 9 (9): e1003227-, 2013

30 Waller RF, "Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum" 95 (95): 12352-12357, 1998

31 Raghu Ram EV, "Nuclear gyrB encodes a functional subunit of the Plasmodium falciparum gyrase that is involved in apicoplast DNA replication" 154 (154): 30-39, 2007

32 Singh D, "Multiple replication origins within the inverted repeat region of the Plasmodium falciparum apicoplast genome are differentially activated" 139 (139): 99-106, 2005

33 Dahl EL, "Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast" 51 (51): 3485-3490, 2007

34 Plowe CV, "Monitoring antimalarial drug resistance : making the most of the tools at hand" 206 (206): 3745-3752, 2003

35 Heuchert A, "Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time : regional surveillance from 2006 to 2013" 14 : 208-, 2015

36 Dar MA, "Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes : unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit" 6 (6): 398-412, 2007

37 Kalanon M, "Malaria, Plasmodium falciparum and its apicoplast" 38 (38): 775-782, 2010

38 Nagaraj VA, "Malaria parasite-synthesized heme is essential in the mosquito and liver stages and complements host heme in the blood stages of infection" 9 (9): e1003522-, 2013

39 Onodera Y, "Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis" 47 (47): 447-450, 2001

40 Jomaa H, "Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs" 285 (285): 1573-1576, 1999

41 McConkey GA, "Inhibition of Plasmodium falciparum protein synthesis. targeting the plastid-like organelle with thiostrepton" 272 (272): 2046-2049, 1997

42 Haussig JM, "Inactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoites" 81 (81): 1511-1525, 2011

43 Sahu R, "In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine" 13 : 414-, 2014

44 Bonday ZQ, "Import of host delta-aminolevulinate dehydratase into the malarial parasite : identification of a new drug target" 6 (6): 898-903, 2000

45 Sawhney B, "Identification of Plasmodium falciparum apicoplast-targeted tRNA-guanine transglycosylase and its potential inhibitors using comparative genomics, molecular modelling, docking and simulation studies" 33 (33): 2404-2420, 2015

46 Li J, "Identification and characterization of a Plasmodium falciparum RNA polymerase gene with similarity to mitochondrial RNA polymerases" 113 (113): 261-269, 2001

47 Miotto O, "Genetic architecture of artemisinin-resistant Plasmodium falciparum" 47 (47): 226-234, 2015

48 Baumeister S, "Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways" 6 (6): e19334-, 2011

49 Shears MJ, "Fatty acid metabolism in the Plasmodium apicoplast: Drugs, doubts and knockouts" 199 (199): 34-50, 2015

50 Imwong M, "Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum" 54 (54): 2886-2892, 2010

51 Jackson KE, "Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum" 42 (42): 177-186, 2012

52 Farooq U, "Drug resistance in malaria" 41 (41): 45-53, 2004

53 Hayton K, "Drug resistance and genetic mapping in Plasmodium falciparum" 54 (54): 223-239, 2008

54 Awab GR, "Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan : an open randomized, non-inferiority, trial" 9 : 105-, 2010

55 Lemgruber L, "Cryo-electron tomography reveals four-membrane architecture of the Plasmodium apicoplast" 12 : 25-, 2013

56 Abrahamsen MS, "Complete genome sequence of the apicomplexan, Cryptosporidium parvum" 304 (304): 441-445, 2004

57 Seliverstov AV, "Comparative analysis of apicoplast-targeted protein extension lengths in apicomplexan parasites" 2015 : e452958-, 2015

58 Yeh E, "Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum" 9 (9): e1001138-, 2011

59 Wilson CM, "Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum" 75 (75): 271-276, 1996

60 Lichtenthaler HK, "Biosynthesis of isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway" 400 (400): 271-274, 1997

61 Morris GM, "AutoDock4 and AutoDock- Tools4: automated docking with selective receptor flexibility" 30 (30): 2785-2791, 2009

62 Dondorp AM, "Artemisinin resistance in Plasmodium falciparum malaria" 361 (361): 455-467, 2009

63 McFadden GI, "Apicomplexan plastids as drugtargets" 7 (7): 328-333, 1999

64 Cilingir G, "ApicoAP: the first computational model for identifying apicoplast-targeted proteins in multiple species of Apicomplexa" 7 (7): e36598-, 2012

65 Qidwai T, "Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum" 15 (15): 374-409, 2014

66 White NJ, "Antimalarial drug resistance" 113 (113): 1084-1092, 2004

67 Pradel G, "Antibiotics in malaria therapy and their effect on the parasite apicoplast" 10 (10): 335-349, 2010

68 Moore RB, "A photosynthetic alveolate closely related to apicomplexan parasites" 451 (451): 959-963, 2008

69 Pham JS, "A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys" 458 (458): 513-523, 2014